Back to Journals » Neuropsychiatric Disease and Treatment

Neuropsychiatric Disease and Treatment

COPE logo
ISSN: 1178-2021

Journal Articles:

- 4,693 records -

Serum GDF-15 Levels in Pediatric ADHD: Associations with Symptom Severity and Stimulant Exposure

Özkan S, Can F, Höbel A

Neuropsychiatric Disease and Treatment 2026, 22:622224

Published Date: 14 July 2026

Changes in Anxiety Severity and Acceptability of Venlafaxine in Generalized Anxiety Disorder in the United States: Results From a Real-World Study

Correll CU, Subramaniam K, Purushottamahanti P, Bayan B, Bryden LA, Palmer EOC, Lipunova N

Neuropsychiatric Disease and Treatment 2026, 22:608897

Published Date: 9 July 2026

Second-Generation Long-Acting Injectable Antipsychotics: A Comprehensive Assessment of Effectiveness, Safety, and Cost

Ifteni P, Petric PS, Popa AV, Teodorescu A, Georgescu R, Manea MC

Neuropsychiatric Disease and Treatment 2026, 22:606817

Published Date: 20 June 2026

Resting-State EEG Characteristics of Tardive Dyskinesia: Spectral and Network Connectivity Insights

Yan L, Xie B, Sun Y, Zheng M, Wang J, Li Y, Chen J, Zhou S, Yu X, Yuan J

Neuropsychiatric Disease and Treatment 2026, 22:595872

Published Date: 20 June 2026

Modifying Neuropsychiatric and Motor Trajectories in Huntington’s Disease Through an Integrated Neurobehavioral Clinic Model

Khan S, Velez Figueroa L, Selvadurai C, Deshpande AR, Najmivarzaneh F, Lindbergh CA

Neuropsychiatric Disease and Treatment 2026, 22:605644

Published Date: 17 June 2026

Validation and Functional Exploration of Exosome-Derived ITGA9-AS1 and WNT5A-AS1 as Candidate Diagnostic Biomarkers for Schizophrenia

Xu Y, Wang Y, Qin F, Yu L, Li W, You X, Guo L, Liu Y, Zeng Y

Neuropsychiatric Disease and Treatment 2026, 22:600571

Published Date: 15 June 2026

Acupuncture for Early Parkinson’s Motor Symptoms: A Multicenter Randomized Controlled Trial Protocol

Zhang J, Xie Y, Huang W, Wu J, Feng L, Li H, Jia X, Zhang X, Tang X, Yu F, Dong Z, Cui S, Liu W, Zhu X, Guo Z, Xu N, Wang L

Neuropsychiatric Disease and Treatment 2026, 22:608205

Published Date: 11 June 2026

Development and Validation of a Prediction Model for Postoperative Delirium

Li L, Qiao N, Yang X, Yang X

Neuropsychiatric Disease and Treatment 2026, 22:592611

Published Date: 9 June 2026

Alcohol Cues Elicit Differences in Brain Activation Patterns of Abstinent Men and Women with Alcohol Use Disorders

Sawyer KS, Oscar-Berman M, Ruiz SM, Marinkovic K, Valmas MM, Harris GJ

Neuropsychiatric Disease and Treatment 2026, 22:551536

Published Date: 8 June 2026

Echinocystic Acid Antagonizes Post-Stroke Depression in Mice by Suppressing the JNK/NF-κB Signaling Pathway

Wang D, Li W, Zhang X, Zhu K, Wang Y, Cai Y, Chen H, Cai X, Sun J

Neuropsychiatric Disease and Treatment 2026, 22:596008

Published Date: 5 June 2026

Peripheral Nerve Conduction in Alzheimer’s vs. Late-Life Depression: A Comparative Study

Li X, Zhao X, Huang Y, Tang J

Neuropsychiatric Disease and Treatment 2026, 22:611214

Published Date: 4 June 2026

Current Evidence of Acetyl-L-Carnitine Use in Mood Disorders-: A Systematic Review and Meta-Analysis

Youtube play button
Youtube thumbnail

Kumar R, Hashempour Z, Shahriarirad S, Shahriarirad R, Hassett LC, Singh B, Croarkin PE, Veldic M, Frye MA, Pagali SR

Neuropsychiatric Disease and Treatment 2026, 22:586506

Published Date: 3 June 2026

Factors Associated with Poor Health-Related Quality of Life Among Patients with Epilepsy at Mulago National Referral Hospital

Atwijukiire H, Namutundu J, Lubogo D, Kaddumukasa M, Sajatovic M

Neuropsychiatric Disease and Treatment 2026, 22:604140

Published Date: 15 May 2026

Comparison of Neurocognitive Effects of Blonanserin, Olanzapine, Aripiprazole, and Risperidone in Drug-Naïve First-Episode Schizophrenia

Hu W, Huang B, Guo X, Yin X, Wang X, Ji Y, Zheng Y, Gao T, Shi C, Yu X, Pu C

Neuropsychiatric Disease and Treatment 2026, 22:603001

Published Date: 13 May 2026

Clinical Benefit and Risk Profile of TV-46000 for Patients with Schizophrenia as Assessed by Number Needed to Treat and Number Needed to Harm

Citrome L, Franzenburg KR, Suett M, Tohami O, Sharon N, Jehassi A, Harary E, Yu D, Correll CU

Neuropsychiatric Disease and Treatment 2026, 22:534730

Published Date: 8 May 2026

Efficacy and Safety of Escitalopram for Major Depressive Disorder in Children and Adolescents: A Systematic Review and Meta-Analysis with Age-Specific Findings

Maneeton B, Maneeton N, Pojanapotha P, Putthisri S, Oon-arom A, Karawekpanyawong N, Kawilapat S, Maneeton P, Srichan K

Neuropsychiatric Disease and Treatment 2026, 22:595606

Published Date: 5 May 2026

Peripheral Blood Regulatory T Cells and IL-6 are Associated with Cognitive Impairment After Acute Ischemic Stroke

Chang Y, Zhang X, Yu C, Zhu L, Sun S, Sun Z

Neuropsychiatric Disease and Treatment 2026, 22:590109

Published Date: 1 May 2026

Optimizing Identification and Management of Depression in Neurological Diseases: A Narrative Review and Expert Perspective

Bartova L, Beuster ML, Bonetti B, Maina G, Morgado P, Nyberg J

Neuropsychiatric Disease and Treatment 2026, 22:575685

Published Date: 1 May 2026

Association Between Frontotemporal Atrophy and Cognitive Impairment in Patients with Schizophrenia Based on Computed Tomography Imaging

Wang Y, Yang J, Ye Y, Lu L, Wang H, Guo P, Hou N, Huang X, Li C

Neuropsychiatric Disease and Treatment 2026, 22:602462

Published Date: 30 April 2026

Long-Term Effectiveness and Safety of LCIG in Romania. 3-year Results from a Prospective, Observational Study (DUOGLOBE)

Szasz JA, Constantin VA, Jianu DC, Dan TF, Dulamea AO, Sabau M, Vasile MT, Bergmann L, Popescu D, Simu MA

Neuropsychiatric Disease and Treatment 2026, 22:564900

Published Date: 28 April 2026

More articles